Levtchenko E N, Wilmer M, de Graaf-Hess A C, van den Heuvel L P, Blom H, Monnens L A
Afd. Kindergeneeskunde, Universitair Medisch Centrum St Radboud, Postbus 9101, 6500 HB Nijmegen.
Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):476-8.
Cystinosis is an autosomal recessive disorder caused by an impaired transport of cystine out of lysosomes. The most severe infantile form of cystinosis starts with Fanconi syndrome at the age of 3-6 months. Untreated patients develop renal failure before the age of 10. The cystinosis gene (CTNS) maps to chromosome 17p13, spans 23 kb and is composed of 12 exons. CTNS encodes a 367 amino acid protein, cystinosin, which is a H(+)-driven lysosomal cystine transporter. It is enigmatic how lysosomal cystine accumulation induces the clinical symptoms. ATP depletion was demonstrated in an experimental model consisting of loading lysosomes with cystine dimethylester. The amino-thiol cysteamine depletes lysosomal cystine content by a disulfide-exchange reaction with cystine. Therapy with cysteamine should be administered as early as possible and continued after a renal transplantation as the extra renal damage still progresses. Improved life expectancy of cystinotic patients requires the attention of internists with a special interest for this rare disorder.
胱氨酸贮积症是一种常染色体隐性疾病,由胱氨酸从溶酶体的转运受损所致。最严重的婴儿型胱氨酸贮积症在3至6个月大时以范科尼综合征起病。未经治疗的患者在10岁前会发展为肾衰竭。胱氨酸贮积症基因(CTNS)定位于17号染色体p13区,跨度为23 kb,由12个外显子组成。CTNS编码一种含367个氨基酸的蛋白质——胱氨酸转运体,它是一种由氢离子驱动的溶酶体胱氨酸转运蛋白。溶酶体胱氨酸蓄积如何引发临床症状仍不清楚。在一个用胱氨酸二甲酯加载溶酶体的实验模型中证实了三磷酸腺苷(ATP)耗竭。氨基硫醇半胱胺通过与胱氨酸的二硫键交换反应消耗溶酶体胱氨酸含量。半胱胺治疗应尽早开始,并在肾移植后继续进行,因为肾外损害仍在进展。胱氨酸贮积症患者预期寿命的提高需要对这种罕见疾病有特殊兴趣的内科医生的关注。